Company Filing History:
1 out of 157 
1 out of 237 Years Active: 2016-2019
Title: The Innovations of Christophe Combadiere
Introduction
Christophe Combadiere is a notable inventor based in Magny le Hongre, France. He has made significant contributions to the field of biochemistry, particularly in the development of peptides that serve as CCR2 antagonists. With a total of two patents to his name, Combadiere's work is recognized for its potential applications in medical science.
Latest Patents
Combadiere's latest patents focus on CCR2 antagonist peptides. The first patent describes a peptide that functions as a CCR2 non-competitive antagonist. The second patent details a peptide comprising the amino acid sequence Thr-Phe-Leu-Lys (SEQ ID NO: 17) or Thr-Phe-Leu-Lys-Cys (SEQ ID NO: 1), which is also useful as a CCR2 non-competitive antagonist peptide. These innovations highlight his expertise in peptide design and its implications for therapeutic applications.
Career Highlights
Throughout his career, Christophe Combadiere has worked with prestigious institutions such as Université Pierre et Marie Curie (Paris 6) and Sorbonne Université. His academic background and research endeavors have positioned him as a key figure in his field.
Collaborations
Combadiere has collaborated with notable colleagues, including Florian Sennlaub and Constance Auvynet. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Christophe Combadiere's contributions to the field of biochemistry through his innovative patents on CCR2 antagonist peptides demonstrate his significant impact on medical research. His work continues to pave the way for advancements in therapeutic applications.